References
- Lipinski CA. (2000). Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods, 44:235–249.
- Cui SX, Nie SF, Li L, Wang CG, Pan WS, Sun JP. (2009). Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm, 35:603–611.
- Patel D, Sawant KK. (2007). Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm, 33:1318–1326.
- Mueller EA, Kovarik JM, van Bree JB, Tetzloff W, Grevel J, Kutz K. (1994). Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm Res, 11:301–304.
- Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci, 29:278–287.
- Narang AS, Delmarre D, Gao D. (2007). Stable drug encapsulation in micelles and microemulsions. Int J Pharm, 345:9–25.
- Charman WN. (2000). Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts. J Pharm Sci, 89:967–978.
- Gao Z-G, Choi H-G, Shin H-J, Park K-M, Lim S-J, Hwang K-J, Kim C-K. (1998). Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int J Pharm, 161:75–86.
- Obata K, Sugano K, Machida M, Aso Y. (2004). Biopharmaceutics classification by high-throughput solubility assay and PAMPA. Drug Dev Ind Pharm, 30:181–185.
- Takata N, Shiraki K, Takano R, Hayashi Y, Terada K. (2008). Cocrystal screening of stanolone and mestanolone using slurry crystallization. Cryst Growth Des, 8:3032–3037.
- Sakai K, Maeda H, Yoshimori T, Obata K, Ogawa Y. (2009). High-throughput formulation screening system for self-microemulsifying drug delivery. Drug Dev Ind Pharm, 35:746–755.
- Sakai K, Yoshimori T, Obata K, Maeda H. (2010). Design of self-microemulsifying drug delivery systems using a high-throughput formulation screening system. Drug Dev Ind Pharm, 36:1245–1252.
- Galia E, Nicolaides E, Hörter D, Löbenberg R, Reppas C, Dressman JB. (1998). Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res, 15:698–705.
- Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci, 29:278–287.
- Groves MJ, Bassett B, Sheth V. (1984). The solubility of 17 beta-oestradiol in aqueous polyethylene glycol 400. J Pharm Pharmacol, 36:799–802
- Serajuddin AT, Sheen PC, Augustine MA. (1986). Water migration from soft gelatin capsule shell to fill material and its effect on drug solubility. J Pharm Sci, 75:62–64.
- Aungst BJ, Nguyen NH, Rogers NJ, Rowe SM, Hussain MA, White SJ, Shum L. (1997). Amphiphilic vehicles improve the oral bioavailability of a poorly soluble HIV protease inhibitor at high doses. Int J Pharm, 156:79–88.
- Wang Y, Sun J, Zhang T, Liu H, He F, He Z. (2011). Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems. Drug Dev Ind Pharm, 37:1225–1230.
- Sheu MT, Wu AB, Lin KP, Shen CH, Ho HO. (2006). Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions. Drug Dev Ind Pharm, 32:595–607.